| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3076183 | Neurología | 2010 | 6 Pages |
Abstract
The corticoids continue to be the treatment of choice in temporal arteritis, however, given the clinical variability of the disease and the special characteristics of this group of patients, usually elderly and with systemic diseases, we believe that individualised treatment with coherent therapeutic guidelines are essential. Currently there is not only treatment with oral glucocorticoids available, although in our patients we can choose to use intravenous mega-doses, anti-platelet treatment, resort to methotrexate or TNF inhibitors in refractory cases, or even consider surgical approaches.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
J. Balsalobre Aznar, J. Porta-Etessam,